logo

For the Inventor, By the Inventor

Hertford, United Kingdom

Kay Elizabeth Murphy

This inventor holds 3 USPTO granted patents. Top assignees: Smithkline Beecham Corporation, Other. Active years: 1998-2005.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kay Elizabeth Murphy. Retrieved from https://idiyas.com/inventor/kay-elizabeth-murphy

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 3

% Patents Active = 66.7

Average Co-Inventor Count = 4.5

ph-index = 3

Forward Citations = 122(Granted Patents)


Location History:

  • Hertford, GB (1998)
  • Herts, GB (2001 - 2005)

Company Filing History:

goldMedal4 out of 2,198 
 
Smithkline Beecham Corporation
 patents
silverMedal1 out of 834,453 
Other
 patents
where one patent can have more than one assignee

Years Active: 1998-2005

Loading Chart...
3 patents (USPTO):Explore Patents
1. 6870030 - ASP2 (2005-03-22),
2. 6319689 - ASP2 (2001-11-20),
3. 5783181 - Therapeutic uses of fusion proteins between mutant IL 4/IL13 antagonists (1998-07-21),

Title: Kay Elizabeth Murphy: Innovator in Alzheimer's Disease and Cancer Research

Introduction

Kay Elizabeth Murphy is a prominent inventor based in Hertford, GB. She has made significant contributions to the fields of biotechnology and medicine, particularly in the development of treatments for Alzheimer's Disease and cancer. With a total of 3 patents, her work has the potential to impact many lives.

Latest Patents

One of her latest patents involves ASP2 polypeptides and polynucleotides. This patent discloses methods for producing such polypeptides by recombinant techniques. Additionally, it outlines methods for utilizing ASP2 polypeptides and polynucleotides in the design of protocols for treating Alzheimer's Disease, cancer, and prohormone processing, among other conditions. Diagnostic assays for these conditions are also included in her innovative work.

Career Highlights

Throughout her career, Kay has worked with notable organizations, including SmithKline Beecham Corporation. Her experience in these companies has allowed her to develop her expertise and contribute to groundbreaking research.

Collaborations

Kay has collaborated with esteemed colleagues such as Conrad Gerald Chapman and David J Powell. These partnerships have further enriched her research and innovation efforts.

Conclusion

Kay Elizabeth Murphy is a trailblazer in the field of biotechnology, with her patents paving the way for advancements in the treatment of serious health conditions. Her dedication to research and innovation continues to inspire others in the scientific community.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…